Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.34 USD | -1.42% | +0.05% | +168.79% |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
May. 09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.29B |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -133M | EV / Sales 2024 * | - |
Net Debt 2024 * | 293M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-18
x | P/E ratio 2025 * |
-17.4
x | Employees | 55 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.09% |
Latest transcript on Vera Therapeutics, Inc.
1 day | -1.65% | ||
1 week | -0.82% | ||
Current month | +6.26% | ||
1 month | -1.37% | ||
3 months | -8.65% | ||
6 months | +217.59% | ||
Current year | +172.98% |
Managers | Title | Age | Since |
---|---|---|---|
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 39 | 21-07-11 |
Kerry Cooper
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 16-05-31 |
Chairman | 63 | 22-05-23 | |
Patrick Enright
BRD | Director/Board Member | 62 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 41.38 | -1.32% | 114 419 |
24-05-16 | 41.94 | -1.76% | 478,564 |
24-05-15 | 42.69 | +4.45% | 433,845 |
24-05-14 | 40.87 | +0.29% | 373,408 |
24-05-13 | 40.75 | -1.38% | 642,761 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+172.98% | 2.29B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.45% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- VERA Stock